Cohance Lifesciences: Jasub holding rises to 5.18% stake

Cohance Lifesciences Limited disclosed that Jasub Property Holdings LLP received 51 lakh shares, or 1.33% of voting capital, through internal block deals dated November 9 and 11, 2026, raising its holding to 5.18% while the identified concert party’s aggregate stake remained 6.36%.

What did Cohance Lifesciences disclose in the filing?

Cohance Lifesciences disclosed an inter-se transfer of 51 lakh equity shares through block deals among the parties named in its Regulation 29(2) disclosure. Jasub Property Holdings LLP filed the disclosure on November 11, 2026, under the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The filing identifies Jasub Property Holdings LLP as the acquirer. It identifies Jasti Property and Equity Holdings Private Limited, acting as sole trustee of the Jasti Family Trust, Mrs. Venkata Subbamma Jasti, Mr. Venkateswarlu Jasti and Mrs. Sudharani Jasti as persons acting in concert, or PAC. The filing answers “No” to whether the acquirer belongs to the promoter or promoter group.

The disclosed transaction dates are November 9, 2026 and November 11, 2026. Cohance Lifesciences is listed on BSE Limited and the National Stock Exchange of India Limited, and its equity share capital and total voting capital were unchanged at 38,25,97,330 equity shares before and after the transfer.

Which Cohance Lifesciences holder received the 51 lakh shares?

Jasub Property Holdings LLP received the 51 lakh Cohance Lifesciences shares and increased its holding to 1.98 crore shares from 1.47 crore shares. Its holding as a percentage of voting capital increased to 5.18% from 3.84%, a movement of 1.33 percentage points.

Jasti Property and Equity Holdings Private Limited, which held shares on behalf of the Jasti Family Trust, recorded the corresponding reduction of 51 lakh shares. Its holding fell to 45.16009 lakh shares, or 1.18% of voting capital, from 96.16009 lakh shares, or 2.51%.

Mrs. Venkata Subbamma Jasti continued to hold 6,000 shares after the November 2026 transfer. Mr. Venkateswarlu Jasti and Mrs. Sudharani Jasti each continued to hold 2,000 shares, with each of the three individual holdings reported as negligible in percentage terms before and after the transfer.

Did the Cohance Lifesciences concert-party stake change?

No, the identified concert party retained 2,43,26,009 Cohance Lifesciences shares, equal to 6.36% of voting capital, before and after the 51 lakh-share transfer. The figures show a reallocation between Jasub Property Holdings LLP and the Jasti Family Trust’s trustee rather than a change in the group’s reported aggregate ownership.

On the fully diluted basis, the concert party’s holding was also unchanged at 5.99%. Cohance Lifesciences reported total diluted share or voting capital of 40,59,80,385 shares, compared with equity share capital and total voting capital of 38,25,97,330 shares.

The difference between the 6.36% voting-capital holding and 5.99% diluted holding follows from the two share-count bases stated in the filing. The filing defines diluted share or voting capital as the total number of shares assuming full conversion of outstanding convertible securities or warrants into equity shares.

How was the Cohance Lifesciences transfer completed?

Cohance Lifesciences said the 51 lakh-share movement was completed as an inter-se transfer through block deals. The filing does not describe it as an open-market purchase, preferential allotment, rights issue or public issue.

The disclosure reports no shares in the nature of encumbrance in the before-and-after holdings, including pledges, liens or non-disposal undertakings. It also records no voting rights held other than through equity shares and no warrants, convertible securities or other instruments entitling the parties to receive voting rights.

The company’s 38,25,97,330-share equity capital did not change across the November 9 and November 11, 2026 transactions. Together with the unchanged aggregate holding of 2,43,26,009 shares, that confirms the disclosed event did not alter Cohance Lifesciences’ reported share capital or the PAC’s combined holding.

What do the Cohance Lifesciences ownership percentages show?

Jasub Property Holdings LLP became the larger disclosed holder within the identified concert party, with 5.18% of Cohance Lifesciences voting capital after the transfer versus 3.84% before it. The Jasti Family Trust’s trustee moved in the opposite direction, to 1.18% from 2.51%.

On the filing’s fully diluted measure, Jasub Property Holdings LLP’s holding rose to 4.88% from 3.62%. The trustee’s holding declined to 1.11% from 2.37%, while the 51 lakh-share transfer represented 1.26% of the stated 40,59,80,385 fully diluted shares.

The filing provides no transaction price or value for the block deals. It also does not state a purpose for the internal transfer, a further acquisition or disposal target, or a plan to alter the 6.36% aggregate voting-capital holding.

Conclusion

The November 2026 disclosure records a 51 lakh-share internal reassignment within the identified concert party in Cohance Lifesciences. Jasub Property Holdings LLP rose from 1.47 crore to 1.98 crore shares and from 3.84% to 5.18%, while the Jasti Family Trust’s trustee fell from 96.16009 lakh to 45.16009 lakh shares; the combined holding stayed at 6.36%.

The filing identifies November 9 and November 11, 2026 as the completed transaction dates but discloses no future stake target, further transfer plan, deal value or scheduled event. Any subsequent disclosure that changes Jasub Property Holdings LLP’s 5.18% holding or the PAC’s 6.36% aggregate position would therefore be the relevant next reported development.